Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer

Amritha Nair, Hsiang Ching Chung, Tingting Sun, Siddhartha Tyagi, Lacey E. Dobrolecki, Rocio Dominguez-Vidana, Sarah J. Kurley, Mayra Orellana, Alexander Renwick, David M. Henke, Panagiotis Katsonis, Earlene Schmitt, Doug W. Chan, Hui Li, Sufeng Mao, Ivana Petrovic, Chad J. Creighton, Carolina Gutierrez, Julien Dubrulle, Fabio StossiJeffrey W. Tyner, Olivier Lichtarge, Charles Y. Lin, Bing Zhang, Kenneth L. Scott, Susan G. Hilsenbeck, Jinpeng Sun, Xiao Yu, C. Kent Osborne, Rachel Schiff, James G. Christensen, David J. Shields, Mothaffar F. Rimawi, Matthew J. Ellis, Chad A. Shaw, Michael T. Lewis, Thomas F. Westbrook

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Fingerprint

Dive into the research topics of 'Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds